Talledo, Arnold A.

HRN: 10-77-37  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2022
CEFUROXIME 1.5GM (VIAL)
08/28/2022
09/04/2022
IV
1.5 Grams
Q8H
Surgical Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration  Wrong Duration

Overall appropriateness: No  Wrong Duration

Intervention



Type of Intervention done:

                    

           


Acceptance: